-
-
Integrating Innovation and Entrepreneurship Empowerment: Protechting 6.0 Global Launch
2023-06-27
(27 June 2023, SHANGHAI, China / LISBON, Portugal) On 22 June 2023, Fosun Foundation announced the launch of the 6th edition of its “Protechting Acceleration Program” (Protechting 6.0) in Lisbon, Portugal. The competition is co-hosted by Fosun Foundation and Fosun’s subsidiaries and member companies including Portuguese insurance group Fidelidade an
-
-
Fosun International Receives 11 Awards Including Most Honored Company 2023 from Institutional Investor
2023-06-25
(26 June 2023) Institutional Investor, an international authoritative financial mediapublished the results of the 2023 Asia Executive Team survey on 21 June. Fosun International (stock code: 00656.HK) received 11 awards including Most Honored Company for its outstanding industry leadership and remarkable achievements in investor relations,which was a significant improvement comp
-
-
Over 10 million passengers travel along Hangzhou-Shaoxing-Taizhou railway
2023-06-24
The Hangzhou-Shaoxing-Taizhou railway is among China's first group of high-speed railway projects funded by a public-private partnership (PPP), with the private sector having a holding status. The 266.9-kilometer rail line, with a designed speed of 350 kilometers per hour, links the cities of Hangzhou, Shaoxing and Taizhou in Zhejiang Province, China.
-
-
Sing for Hope Pianos Launched on Fosun Plaza
2023-06-23
Largest Annual Public Arts Project in the United States featured free performances from Rwandan Women’s Drumming Group, Sing for Hope Youth Choir, LaGuardia High School ChorusesNEW YORK – Recently, Sing for Hope unveiled twenty artist-designed pianos at 28 Liberty’s Fosun Plaza. The event featured open-play for the public and pop-up performances throughout the day from a
-
-
First Patient Dosed of Phase 2 Clinical Trial of Serplulimab in Combination with Innovative Anti-LAG-3 mAb for the Treatment of Metastatic Colorectal Cancer Patients
2023-06-15
Shanghai, China, June 15th, 2023 - Shanghai Henlius Biotech, Inc. (2696.HK) announced that the first patient has been dosed in a phase 2 clinical trial (NCT05584137) of HANSIZHUANG (serplulimab injection), an innovative anti-PD-1 monoclonal antibody (mAb) independently developed by the company, in combination with HLX26, an innovative anti-LAG-3 mAb for the trea
-
-
Fosun Ranks 5th on China ESG (Corporate Social Responsibility) Release’s List of China’s Top 100 ESG Listed Companies
2023-06-14
On the afternoon of 13 June 2023, the Financial Program Center of China Media Group (CMG), together with the State-owned Assets Supervision and Administration Commission of the State Council (SASAC), the All-China Federation of Industry and Commerce (ACFIC), the Institute of Economics of the Chinese Academy of Social Sciences (CASS), the China Enterprise R
-
-
Henlius Shines for Five Consecutive Years at BIO International Convention
2023-06-12
-
-
Wolves announce Partnership with Shede Spirits
2023-06-09
The new partnership will see Shede’s Tuopai brand become the club’s Official Baijiu Partner for the 2023/24 season.Tuopai is one of the best known and well renowned liquor brands in China.With sales of over five billion bottles in the country, Tuopai has left a profound impression on generations of Chinese people, and the partnership with Wolves will further grow the b
-
-
Investor Open Day: Fosun Implements Business Streamlining and Resilience Building Strategy, Focusing on Core Businesses to Bring New Vitality
2023-06-08